Company Directory > Biotech > Paradigm Pharmaceuticals Inc.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Paradigm Pharmaceuticals Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Paradigm Pharmaceuticals Inc. is a U.S.-based company that specializes in licensing and marketing high-quality branded generics and complementary nutraceuticals. The company focuses on making affordable medicines and dietary supplements accessible, particularly in Asian markets, and operates with a mission to bridge the gap between prevention and treatment for chronic diseases. Headquartered in New York, the company maintains significant operations in ASEAN countries, with a regional hub in Bangkok, Thailand. It frequently partners with established pharmaceutical manufacturers to distribute products indicated for conditions such as hypertension, diabetes, cholesterol, pain, and infections, alongside a portfolio of probiotics and herbal supplements.
CLASSIFICATION
Company Type:Biotech
Industry:Pharmaceuticals
Sub-Industry:Branded Generics & Nutraceuticals
SIZE & FINANCIALS
Employees:51-200
Revenue:<$10M
Founded:2008
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Paradigm Pharma (Thailand) Co., Ltd.
Key Partnerships:Berlin Pharmaceutical Industry Co. Ltd. (Affiliated manufacturing partner)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Amal Naj - CEO
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Paradigm Pharmaceuticals Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.